Single-Use Negative Pressure Wound Therapy Devices Market projected to reach US$ 892.32 million by 2028 to grow at a CAGR of 8.7%

Single-Use Negative Pressure Wound Therapy Devices Market projected to reach US$ 892.32 million by 2028 to grow at a CAGR of 8.7%

Single-Use Negative Pressure Wound Therapy Devices Market
The single-use negative pressure wound therapy devices market was valued at US$ 462.05 million in 2020, and it is projected to reach US$ 892.32 million by 2028; it is expected to grow at a CAGR of 8.7% from 2021 to 2028.

The single-use negative pressure wound therapy devices market is segmented on the basis of wound type, end user, and geography. Based on geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the single-use negative pressure wound therapy devices market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes COVID-19 impact analysis across all the regions. It is estimated that the market is likely to grow at a steadily increasing rate during the forecast period owing to the need of single-use negative pressure wound therapy devices to treat acute and chronic wounds occurred during the COVID-19 treatment.

Negative pressure wound therapy (NPWT) is used for managing a wide range of wound types, including traumatic, hard-to-heal, and chronic wounds. It is also used to manage wounds that are covered with flaps or a skin graft. NPWT  is transformed into a medical device such as a single-use NPWT device, and it is a small pocket-sized battery-operated device. As the name suggests, these are disposable and portable devices generally used for outpatient care.

Request for sample PDF Copy at:

Prominent players operating in single-use negative pressure wound therapy devices market include Cardinal Health Inc; ConvaTec Group Plc; Carilex Medical; Genadyne Biotechnologies, Inc.; H and R Healthcare; Lohmann & Rauscher GmbH & Co. KG; Medela AG; Mölnlycke Health Care AB; Paul Hartmann Ag; and Smith & Nephew plc. The companies have maximized their growth with several organic strategies to enhance the market value and maintain position in the market. For instance, in March 2020, Smith & Nephew launched its new PICO 14 Single Use Negative Pressure Wound Therapy System. It has a pump duration of up to 14 days. The pump is based on previous PICO sNPWT variants’ innovations and advantages. The pump is so enhanced that it requires less user intervention. Such constant developments in the existing products are required to offer efficient product quality and services for improving patient’s health.

Chronic diseases and their associated disorders are among the major indications affecting the human population globally. As per the National Center for Chronic Disease Prevention and Health Promotion, these diseases persist for one year or more and may require medical attention for performing daily activities. Moreover, as per the Centers for Disease Control and Prevention (CDC’s) data in January 2021, chronic diseases such as heart disease, cancer, and diabetes are among the leading causes of morbidity, mortality, and disability in the US. It is estimated to account for ~US$ 3.8 trillion in the nation’s annual health care expenses. Chronic diseases can cause long-term injuries and make the healing of wounds, such as post-surgical wounds and accident-led wounds, difficult. Different types of devices are used to manage the wounds as the wounds need to be cleaned regularly. Negative pressure wound therapy systems are used to manage and ease wound healing. It is an FDA Class II device that operates on a battery or electricity, and each device consists of a vacuum pump, drainage tubing, and wound dressing set. The systems help in wound-healing through negative pressure (suction). They also help remove fluids such as irrigation solutions, bodily liquids, wound exudate, and infectious materials present in the wound area.

According to a study published by the National Center for Biotechnology Information in August 2020, diabetic foot ulcers were among the possible causes of non-traumatic amputations in the US. About 5% of patients suffering from diabetes mellitus develop foot ulcers, and 1% need an amputation procedure. The patients in such conditions require periodic wound cleaning and dressing that can be accomplished using wound therapy devices. Continuous developments in medical devices related to wound therapy, as well as rise in prevalence of diseases such as diabetes, cancer, and diabetes—which might lead to ulcers, pressure ulcers, and wounds associated with different surgical procedures—are driving the single-use negative pressure wound therapy market.

The report segments the global single-use negative pressure wound therapy devices market as follows:

By Wound Type

  • Surgical
  • Traumatic
  • Diabetic Foot
  • Sports Injuries
  • Venous Leg Ulcers
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

Purchase a copy of the report @

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876

Email: [email protected]


Media Contact
Company Name: The Insight Partners
Contact Person: Sameer Joshi
Email: Send Email
Phone: +1-646-491-9876
City: Pune
State: Maharashtra
Country: India